ADIA is the peak business organisation representing manufacturers and suppliers of dental products. Our vision is for an industry that empowers oral health professionals to advance the health and wellbeing of all Australians...................... — ADIA Strategic Plan

Media Release —
Senate Report Backs Dental Industry Views On Red-Tape

a

— 31 April 2018
For Immediate Release

.

A Senate committee has accepted advice from the Australian Dental Industry Association (ADIA) that although the Australian Government has a strong track-record of reducing red-tape in the healthcare sector there remains considerable scope for continued reform.

As the peak business organisation representing businesses that manufacture and supply innovative dental products, ADIA made a submission to the Senate Red-Tape Committee’s inquiry into red-tape in the health sector. ADIA’s submission was referenced extensively in the committee’s report.

“The Senate committee’s report highlighted the significant progress of the Australian Government in reducing red-tape in the therapeutic products sector but also stressed the need for ongoing reform to reduce burdensome and duplicative compliance burden,” said Troy Williams, ADIA Chief Executive Officer.

In its submission to the Senate inquiry ADIA acknowledged that regulators such as the Therapeutic Goods Administration (TGA) had done much to reduce red-tape in the sector.

“This report highlights the fact that although the Australian Government has made significant progress in reducing red-tape for businesses in the dental industry, the is still a lot to do in order for businesses across the sector to grow, create jobs and operate sustainability,” Mr Williams said.

Recognising the concerns of the dental industry, the Senate committee’s report cited ADIA recommendations where further reform is needed such as the regulation of teeth whitening products and the difference in licensing between state / territory governments as to who can own and operate Cone Beam Computed Tomography (CBCT) digital imaging equipment.

“In many respects the biggest challenges to reducing red-tape now rest with the complexity that comes with Australia’s federation, where the policy priorities of the Australian Government, state governments and territory governments don’t align. For manufacturers and suppliers of innovative dental products this results in a regulatory compliance burden that, to this day, remains too high,” Mr Williams said.

ADIA endorses the views of the Senate committee that notes that the regulatory reform agenda requires a whole-of-government effort toward red-tape reduction. In fulfilling this agenda, the Senate committee encouraged all departments and agencies to be aware not just of their regulatory environment but also those with which they interact, something that ADIA continues to press for.

“In actively lobbying for reform, ADIA is working towards a regulatory framework for dental products that is based on a risk management approach designed to ensure public health and safety, while at the same time freeing industry from any unnecessary regulatory burden.” Mr Williams said.

Ends.

Photograph —

. Troy Williams - ADIA Chief Executive Officer [PDF]

.
Media Contact —

ADIA Communications Officer
t: 1300 943 094.....e: media@adia.org.au

A — A D I A . .S T R A T E G I C . .A L L I A N C E S

a

Dental Industry News

  • TGA Plan To Achieve Global Regulatory Harmonisation

    28th Sep 18

    The Therapeutic Goods Administration (TGA) has released its operations plan to harmonise Australia’s regulatory framework for therapeutic products with that of comparable overseas jurisdictions, which will cut red-tape and make it easi More

  • TGA Publishes Draft Advertising Guidance

    15th Aug 18

    The dental industry is playing a lead role in supporting the TGA develop industry guidance on the 2018 TGA Therapeutic Goods Advertising Code, a document that sets clear standards for advertising medical devices to consumers. More